Immunotherapy research and treatment has generated excitement and progress in healthcare. It’s a treatment that is providing patients with a new, lower toxicity way of treating their cancer, and it uses the power of the patient’s immune system. Seattle Cancer Care Alliance and our partners are no stranger to progressive therapies. Bone marrow transplantation is heralded as one of the most groundbreaking discoveries in the history of cancer treatment; with this procedure, Fred Hutch laid the foundation for immunotherapy in the 1970s when they spurred discoveries that our immune systems could be made to treat our cancer. We heard from one of our experts, Dr.
For one of Seattle Cancer Care Alliance's top oncology doctors, over treating and under treating patients is not an option. "We need to tailor the therapy," SCCA's Dr. Ajay Gopal said. Gopal said physicians are working to provide patients with individualized therapies specific to each diagnosis. His remarks were among the latest groundbreaking findings to surface at the American Society of Hematology in San Diego, a national conference dedicated to the latest research in blood cancers. Gopal talked about clinical trials he shared with colleagues, including a new immunotherapy trial that could be an effective, lower toxicity option for patients with follicular lymphoma.
If you had just 10 seconds to share your message to others for better health in 2016, what would it be? Would it be getting more phytonutrients into your diet? Going on more walks with your special someone? Taking more deep breaths throughout the day? I wanted to hear from our experts, staff and care team. In January, I pooled together tips from our providers and staff in the form of 10 second video clips for a social media series called #BetterHealthIn10: 10 second clips delivering an important idea, tip or practice that patients and families can adopt to make positive changes in their lives this year. I set out to start the year, and my new job as social media producer here at SCCA, in a positive way that would give our community a new way to think about their health.
The American Society of Clinical Oncology (ASCO) held its annual meeting earlier this month where medical professionals across the country presented findings on cancer treatments. Several SCCA doctors talked with Patient Power’s Carol Preston about their specific fields. Below are videos of those interviews that discuss colorectal, breast and prostate cancers. The Importance of Genetics in Colorectal Cancer It used to be that a standard course of treatment for colorectal cancer was based on the cancer’s stage—the size and extent of where the cancer has spread inside the body. In this interview, Dr.
Below is a collection of video interviews that our doctors had with Patient Power’s Carol Preston at this year's annual meeting of the American Society of Clinical Oncology (ASCO), which took place in Chicago earlier this month. The interviews focus on the latest advances in treating prostate cancer, breast cancer, pancreatic cancer, sarcoma, and colorectal cancer. Adding Chemotherapy Early On in the Treatment of Advanced Prostate Cancer Dr. Heather Cheng discusses the results of a clinical trial which showed that using chemotherapy early on for patients with metastatic prostate cancer makes a big difference. Up until now, hormone therapy was the mainstay for men with advanced disease, but as Dr.